SCHEMBL23155167

SCHEMBL23155167

c1ccc2c(c1)-c1cccc3c1-c1cc(N(c4ccc5oc6ccccc6c5c4)c4cccc5ccccc45)ccc1-c1cccc-3c1-2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.35
▸ HPGD P15428 4/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ GAA P10253 1/20 0.33
▸ AHR P35869 2/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ DNMT1 P26358 1/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ GLA P06280 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ DUSP3 P51452 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23155169 0.93 DUSP3 (0.36) MAPTHPGDKDM4EALDH1A1KMT2A
SCHEMBL23155358 0.88 L3MBTL1 (0.33) HPGDALDH1A1ALOX5DNMT1HSD17B10
SCHEMBL23155359 0.87 ALOX5 (0.40) MAPTHPGDKDM4EALDH1A1GAA
SCHEMBL23155228 0.87 NPC1 (0.35) MAPTHPGDKDM4EALDH1A1KMT2A
SCHEMBL23155245 0.87 ALDH1A1 (0.36) MAPTHPGDKDM4EALDH1A1KMT2A
SCHEMBL25580574 0.85 KDM4E (0.34) MAPTHPGDKDM4EALDH1A1KMT2A
SCHEMBL23155370 0.85 MAPT (0.39) MAPTHPGDKDM4EALDH1A1KMT2A
SCHEMBL23155156 0.85 DNMT1 (0.40) MAPTHPGDKDM4EALDH1A1KMT2A
SCHEMBL25580232 0.84 KDM4E (0.33) MAPTHPGDKDM4EALDH1A1KMT2A
SCHEMBL25580865 0.84 KDM4E (0.33) MAPTHPGDKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-28 — — US disclosed
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-01 — — US disclosed
EP-3799144-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME Samsung Display Co., Ltd. (KR) 2021-03-31 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same CRY1, SMCHD1, CXCR1 MAPT 4116/4885HPGD 2231/4885KDM4E 2359/4885
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME CRY1, SMCHD1, CXCR1 MAPT 4116/4885HPGD 2231/4885KDM4E 2359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback